# Parker-Hannifin Corp: overview

PH · NYSE · CIK 76334 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ph.md) · [Financials](/companies/ph/financials.md) · [Filings](/companies/ph/filings.md) · [Insiders](/companies/ph/insiders.md)

Latest reported revenue: [$5.75bn](/filings/0000076334-26-000105.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Aug 21, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000076334-26-000105).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,904](/filings/0000076334-25-000071.md) | [4,743](/filings/0000076334-26-000008.md) | [4,960](/filings/0000076334-26-000073.md) | [5,243 d](/filings/0000076334-26-000105.md) | [5,084](/filings/0000076334-25-000071.md) | [5,174](/filings/0000076334-26-000008.md) | [5,486](/filings/0000076334-26-000073.md) | [5,755 d](/filings/0000076334-26-000105.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [21.6%](/filings/0000076334-25-000071.md) | [20.9%](/filings/0000076334-26-000008.md) | [22.3%](/filings/0000076334-26-000073.md) | [22.7% d](/filings/0000076334-26-000105.md) | [23.3%](/filings/0000076334-25-000071.md) | [22.8%](/filings/0000076334-26-000008.md) | [22.4%](/filings/0000076334-26-000073.md) | [25.6% d](/filings/0000076334-26-000105.md) |
| Net margin | % | [14.2%](/filings/0000076334-25-000071.md) | [20.0%](/filings/0000076334-26-000008.md) | [19.4%](/filings/0000076334-26-000073.md) | [17.6% d](/filings/0000076334-26-000105.md) | [15.9%](/filings/0000076334-25-000071.md) | [16.3%](/filings/0000076334-26-000008.md) | [16.5%](/filings/0000076334-26-000073.md) | [19.0% d](/filings/0000076334-26-000105.md) |
| Diluted EPS | $ per share | [5.34](/filings/0000076334-25-000071.md) | [7.25](/filings/0000076334-26-000008.md) | [7.37](/filings/0000076334-26-000073.md) | not reported | [6.29](/filings/0000076334-25-000071.md) | [6.60](/filings/0000076334-26-000008.md) | [7.06](/filings/0000076334-26-000073.md) | not reported |
| Free cash flow | $m | [649](/filings/0000076334-25-000071.md) | [814 d](/filings/0000076334-26-000008.md) | [542 d](/filings/0000076334-26-000073.md) | [1,336 d](/filings/0000076334-26-000105.md) | [693](/filings/0000076334-25-000071.md) | [768 d](/filings/0000076334-26-000008.md) | [881 d](/filings/0000076334-26-000073.md) | [1,563 d](/filings/0000076334-26-000105.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [15.9](/filings/0000076334-24-000044.md) | [19.1](/filings/0000076334-25-000035.md) | [19.9](/filings/0000076334-26-000105.md) | [19.9](/filings/0000076334-26-000105.md) | [21.5](/filings/0000076334-26-000105.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [18.8%](/filings/0000076334-24-000044.md) | [17.9%](/filings/0000076334-25-000035.md) | [20.4%](/filings/0000076334-26-000105.md) | [21.9%](/filings/0000076334-26-000105.md) | [23.6%](/filings/0000076334-26-000105.md) |
| Net margin | % | [8.3%](/filings/0000076334-24-000044.md) | [10.9%](/filings/0000076334-24-000044.md) | [14.3%](/filings/0000076334-24-000044.md) | [17.8%](/filings/0000076334-26-000105.md) | [17.0%](/filings/0000076334-26-000105.md) |
| Diluted EPS | $ per share | [10.09](/filings/0000076334-24-000044.md) | [16.04](/filings/0000076334-25-000035.md) | [21.84](/filings/0000076334-26-000105.md) | [27.12](/filings/0000076334-26-000105.md) | [28.48](/filings/0000076334-26-000105.md) |
| Free cash flow | $bn | [2.2](/filings/0000076334-24-000044.md) | [2.6](/filings/0000076334-25-000035.md) | [3.0](/filings/0000076334-26-000105.md) | [3.3](/filings/0000076334-26-000105.md) | [3.9](/filings/0000076334-26-000105.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ph/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $10.16bn | 10,390,711 |  | Added +389,828 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $9.18bn | 9,385,389 |  | Added +42,548 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.05bn | 8,234,180 |  | Added +33,487 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.81bn | 3,894,862 |  | Reduced −152,555 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $3.27bn | 3,346,733 |  | Reduced −136,862 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.81bn | 2,890,496 |  | Reduced −28,548 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.53bn | 2,581,520 |  | Added +27,164 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.96bn | 2,006,884 |  | Reduced −346,006 |
| [Aristotle Capital Management, LLC](/funds/860644.md) | 2026-06-30 | $1.96bn | 1,998,974 |  | Reduced −122,400 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $1.93bn | 1,975,158 |  | New +1,975,158 |

## Recent filings

[All 2,163 filings](/companies/ph/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 09:00 ET | [DEF 14A](/filings/0001308179-26-000394.md) | Proxy statement, period 2026-10-28 | 0001308179-26-000394 |
| 2026-09-14 | 16:05 ET | [8-K](/filings/0001193125-26-390561.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-390561 |
| 2026-09-10 | 16:11 ET | [8-K](/filings/0001193125-26-387884.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387884 |
| 2026-09-08 | 08:16 ET | [8-K](/filings/0001193125-26-384428.md) | 8.01 Other events | 0001193125-26-384428 |
| 2026-08-21 | 08:00 ET | [10-K](/filings/0000076334-26-000105.md) | Annual report, period 2026-06-30 | 0000076334-26-000105 |
| 2026-08-13 | 16:05 ET | [8-K](/filings/0001193125-26-349148.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-349148 |
| 2026-08-06 | 07:59 ET | [8-K](/filings/0000076334-26-000082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000076334-26-000082 |
| 2026-05-01 | 07:57 ET | [10-Q](/filings/0000076334-26-000073.md) | Quarterly report, period 2026-03-31 | 0000076334-26-000073 |
| 2026-04-30 | 07:59 ET | [8-K](/filings/0000076334-26-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000076334-26-000070 |
| 2026-03-17 | 16:10 ET | [8-K](/filings/0001193125-26-110795.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-110795 |

## Latest annual report

[Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0000076334-26-000105.md), filed Aug 21, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c7620e99-0e29-4daf-8df7-6721ba1668cb)

## About the filer

- CIK: 76334
- Tickers: PH
- Exchange: NYSE
- SIC code: 3490 Miscellaneous Fabricated Metal Products
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:27 ET. No prices; not investment advice.